RADAR-AD Project| Ongoing | IMI2 | Neurodegenerative diseasesAlzheimer's diseaseRADARDigital healthBig data and knowledge management Remote assessment of disease and relapse – Alzheimer’s disease
IM2PACT Project| Ongoing | IMI2 | Diabetes & metabolic disordersNeurodegenerative diseasesAlzheimer's diseaseTools for predicting/monitoring efficacyDrug delivery Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
VITAL Project| Ongoing | IMI2 | Ageing-associated diseasesInfectious diseasesVaccinesTools for predicting/monitoring efficacyReal-world data, evidence Vaccines and infectious diseases in the ageing population
EHDEN Project| Ongoing | IMI2 | BD4BOBig data and knowledge managementReal-world data, evidence European Health Data and Evidence Network
VHFMoDRAD Project| Ongoing | IMI2 | Infectious diseasesEbola and related diseasesDiagnosticsEbola+ Viral haemorrhagic fever: modern approaches for developing bedside rapid diagnostics
WEB-RADR 2 Project| Ongoing | IMI2 | Tools for predicting/monitoring safetyBig data and knowledge managementReal-world data, evidenceRegulatory and HTA processesMethods for benefit/risk assessment WEB-RADR 2
GetReal Initiative Project| Ongoing | IMI2 | Clinical trial designReal-world data, evidenceRegulatory and HTA processes The GetReal Initiative
EFOEUPATI Project| Ongoing | IMI2 | Patient involvement in R&DEducation and training Ensuring the future of EUPATI beyond 2020
'Patient organisations have a unique role in IMI projects' - a video interview with Jean Georges of Alzheimer Europe News | 08/01/2019 | Testimonials We sat down with Jean Georges, executive director of Alzheimer Europe, and asked him to describe the value of bringing patient organisations into IMI projects.
'To get into an IMI project, you have to network' - a video interview with Tamas Letoha of Pharmacoidea News | 08/01/2019 | Testimonials We sat down with Tamas Letoha, CEO of Pharmacoidea in Hungary, to speak about his experience working on IMI projects, and his advice for other SMEs.